Welcome to the Media Centre

The BIA Media Centre is a resource space for journalists and members of the press who are looking for information and experts on key issues within the UK biotech and life sciences sector.

The BioIndustry Association (BIA) is the voice of the innovative life sciences and biotech industry, enabling and connecting the UK ecosystem so that businesses can start, grow and deliver world-changing innovation. We work with our members and partners to champion innovation, attract and develop talent, drive investment, build global partnerships, influence policy, and engage the ecosystem.

In this Media Centre, you will find:

  • Press releases and statements on the latest news and developments in the UK biotech and life sciences sector.
  • Backgrounders on key issues, such as regulation, funding and intellectual property.
  • Experts for interviews on a range of topics.
  • A calendar of events, including industry conferences and trade shows.

  • The UK accounts for 35% of all life science start-ups created in Europe since 2012, according to data published by McKinsey.
  • Government figures show there are over 6,548 businesses in the UK life sciences industry, and approximately 70-80% are small and medium-sized enterprises. These businesses employ over 282,000 people and generated £94.2 billion of turnover in 2021. The number of businesses and the number of sites operated by these businesses have both seen an upward trend since 2009, with 23% more businesses and 32% more sites operating across the UK in 2021 compared to 2009.
  • Investment in UK life science start-ups and scale-ups as risen from £261 million in 2012 to £1.8 billion in 2022, but fluctuates significantly depending on global macro-economic factors. More UK-based investment is required to complement overseas capital.   
  • Medical innovation is driven by smaller companies, which represent 65% of the global drug development pipeline with an additional 7% being developed by them in partnership with larger firms, according to data published by IQVIA.

BIA was founded in 1989 and has over 500 members, including start-ups, SMEs, pharmaceutical companies, universities and charities. We are headquartered in Bloomsbury, London and are the leading voice in the UK life sciences sector, regularly consulted by the government on key policy issues.

About the BioIndustry Association (BIA)

The BioIndustry Association (BIA) is the voice of the innovative life sciences and biotech industry, enabling and connecting the UK ecosystem so that businesses can start, grow and deliver world-changing innovation.

Helping biotech and life sciences sector to influence, connect and save.  www.bioindustry.org


 Latest press releases


Deep Biotech will deliver a more sustainable future, and BIA is its new voice

Deep Biotech encompasses innovative companies harnessing the power of engineering biology to tackle humanity's most pressing challenges, from environmental pollution to climate change. From cultivating meat without animals to crafting bio-based materials that replace harmful plastics, Deep Biotech offers a sustainable roadmap for a greener future. 

Professor Sir Mene Pangalos wins Lifetime Achievement Award at the BIA’s Gala Dinner

Mene led AstraZeneca's pharmaceutical discovery and early development through a key period of growth and innovation and was a driving force for scientific excellence and collaboration. Joining the company in 2010, Mene transformed AstraZeneca’s approach to R&D, fostering deeper academic and industry partnerships, pioneering Open Innovation programmes, and building a culture that values truth-seeking in science.

Resilient UK biotech sector lands £1.8 billion investment in 2023

New report highlights sector's strength, investor confidence and long-term returns. London-quoted biotechs also continue to outperform UK and US markets over the long term, having made substantial gains during the pandemic that have not been lost.   

BIA unveils new data: UK leads Europe in cell and gene therapy as sector makes significant strides  

The UK is cementing its position as a global leader in cell and gene therapy, according to a new report released today by the UK BioIndustry Association (BIA), in collaboration with Citeline.  

BIA reaches 600 member companies, announces new board and leadership restructure 

The UK’s innovative trade association for life science and biotech companies, BioIndustry Association (BIA), today announces that it has reached 600 companies in membership for the first time ever, alongside new Board and staff appointments for 2024.

BIA announces its Charity Partnership for 2024 with RNID

BIA is thrilled to announce its charity partnership of the year for 2024 with RNID, the national charity supporting the 12 million people in the UK who are deaf, have hearing loss or tinnitus. 

Resources and reports 

Deep Biotech: Disruptive innovation for global sustainability

The BIA has coined the term ‘Deep Biotech’ to capture companies working in this biotech space. This report aims to shine a light on some of the innovative companies using engineering biology to positively disrupt the environmentally damaging industries that modern society relies on.

UK biotech financing 2023

Despite the global economic downturn, UK life sciences companies secured £1.25 billion in venture financing, constituting 11% of the total venture capital investment in UK companies this year.

BIA's submission to HMT's Spring Budget 2024

The BIA has submitted a representation to HM Treasury ahead of the Spring Budget scheduled for March.

Influencing and shaping our sector BIA update: October 2023 - January 2024

An overview of the BIA's influencing work on behalf of the innovative life science and biotech sector between October 2023 and January 2024.